asthma
It recently obtained a 510(k) clearance from the US and funding for its expansion in Southeast Asia.
It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.
The NUHS will facilitate the study on AeviceMD's use in detecting wheezing among paediatric patients with breathing difficulties.
The Digihaler line is equipped with Bluetooth wireless technology that automatically records inhaler-use data every time the cap is opened or a user inhales.
The 900-participant study uses learnings from Apple's Tueo Health acquisition and could inform the development of a digital biomarker for asthma.
The new expansion is linked to a partnership the digital health company has with Novartis.
The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year.
The co-packaged product, which will be launched in Europe this year, combines Propeller's sensor tech and Novartis' new medication.
Panelists at BIO Digital discuss the obstacles of implementing digital tools to treat asthma and COPD patients, as well as the opportunity.
The digital respiratory health company says this deal and clearance now give it access to 90% of the U.S. asthma and COPD market.